Please check your internet connection and try again.
## Norepinephrine (Levophed)
### Overview
Norepinephrine is a potent alpha-1 adrenergic agonist and a weaker beta-1 adrenergic agonist. It causes peripheral vasoconstriction, increasing systemic vascular resistance and blood pressure. Beta-1 agonism can increase myocardial contractility and heart rate. It is typically administered via continuous intravenous infusion.
### Primary Indications
* Treatment of severe Hypotension and shock, particularly when unresponsive to fluid resuscitation.
* Restoration and maintenance of blood pressure in septic shock and cardiogenic shock.
### Adult Dosing
* **Initial Dose:** 0.01 to 0.02 mcg/kg/min IV.
* **Titration:** Increase dose every 5-15 minutes as needed to achieve target blood pressure (often a mean arterial pressure [MAP] of 65 mmHg or higher, though specific targets may vary based on patient condition and local protocol).
* **Maximum Dose:** Doses up to 0.1 mcg/kg/min may be required in severe cases. Some sources cite higher maximums, but doses exceeding 0.1 mcg/kg/min are associated with increased risk of adverse effects.
### Pediatric Dosing
* **Initial Dose:** 0.05 to 0.1 mcg/kg/min IV infusion.
* **Titration:** Adjust infusion rate to maintain desired blood pressure. Doses may be increased incrementally.
* **Maximum Dose:** Typically up to 1 mcg/kg/min, but doses above 0.1 mcg/kg/min should be used cautiously.
### Dose Adjustments
* **Renal Impairment:** No specific dose adjustment is recommended, but caution is advised as renal perfusion may be further compromised.
* **Hepatic Impairment:** No specific dose adjustment is recommended.
* **Elderly:** No specific dose adjustment is recommended.
### Contraindications
* Hypersensitivity to norepinephrine.
* Use as the sole agent to maintain blood pressure in patients with profound volume deficit before adequate fluid resuscitation is achieved.
* Patients with occlusive vascular diseases (e.g., peripheral vascular embolism, thrombosis) unless it is a dire emergency.
### Adverse Effects
* **Common:** Hypertension, bradycardia (reflex), peripheral ischemia, extravasation leading to tissue necrosis, headache, anxiety, tremors, dizziness.
* **Serious:** Arrhythmias, acute heart failure, pulmonary edema, decreased cardiac output, gangrene, reduced splanchnic blood flow.
### Key Drug Interactions
* **Monoamine Oxidase Inhibitors (MAOIs) and Tricyclic Antidepressants (TCAs):** Potentiate the pressor response; concurrent use is generally contraindicated or requires extreme caution and dose reduction.
* **General Anesthetics:** May increase the risk of arrhythmias.
* **Beta-blockers:** May unopposed alpha-adrenergic effects leading to severe hypertension.
* **Alpha-blockers:** May antagonize the vasoconstrictive effects.
* **Ergot alkaloids:** May potentiate the vasoconstrictive effects.
### Monitoring
* Continuous ECG monitoring for arrhythmias.
* Frequent blood pressure monitoring (intra-arterial preferred for accuracy).
* Central venous pressure (CVP) and/or pulmonary artery catheter (PAC) monitoring if available.
* Urine output.
* Peripheral perfusion (skin temperature, color, capillary refill).
* Infusion site for signs of extravasation.
* Arterial blood gases and lactate levels to assess tissue perfusion.
### Clinical Pearls
* Norepinephrine should be diluted in a compatible IV fluid (e.g., D5W or NS) before administration.
* Administer via a central venous catheter to minimize risk of extravasation and tissue necrosis. If only a peripheral IV is available, use a large vein and monitor closely.
* Have phentolamine readily available for immediate treatment of extravasation.
* Titrate to the lowest effective dose to achieve the desired hemodynamic endpoint.
* Reassess the underlying cause of hypotension and continue or transition to alternative vasopressors or therapies as the patient's condition improves.
***
*Disclaimer: This information is intended for healthcare professionals. Always consult the official prescribing information and current clinical guidelines for complete details and to ensure patient safety. Drug dosing and management can be complex and should be individualized.*
